• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, July 15, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Drug companies selling more ‘lifestyle,’ less ‘symptom’

Bioengineer by Bioengineer
May 15, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

TAMPA, Fla. (May 15, 2018)- Prescription drug commercials are getting longer and providing less factual information. A study published in the Annals of Family Medicine finds that the majority of these ads focus on lifestyle improvements made post-medication rather than side-effects and the negative emotions associated with certain health issues.

The team of researchers lead by the University of South Florida in Tampa compared prescription drug commercials from 2016 to results from a related study conducted in 2004. They found 56.9% of ads portrayed actors as regaining control and social approval, along with improved endurance in physical activities such as bicycling and hiking. That's up from 39.5% of ads monitored in the previous research.

"Direct-to-consumer advertising continues to promote prescription drugs above educating the population," said lead author Janelle Applequist, PhD, assistant professor at the University of South Florida Zimmerman School of Advertising and Mass Communications. "Such expansive promotion of drug benefits could imply off-label outcomes and encourage an inappropriately broad population to seek the advertised drug."

While the commercials were 30-percent longer, they contained significantly less information about the medical condition in itself. The percentage of ads that explain associated risk factors dropped 26 percent to 16 percent and the condition's prevalence went from 25 percent to 16 percent. Few ads emphasized the importance of combining the medication with improved diet and exercise.

The researchers come to this conclusion after monitoring the networks ABC, NBC, CBS and FOX during primetime hours for 13 weeks. During that time, they say the networks aired 868 prescription drug commercials, 61 if you remove duplicates.

Dr. Applequist says these findings prove a need for policymakers to take regulatory action in order to ensure pharmaceutical ads promote health and disease awareness above product endorsement.

###

Media Contact

Tina Meketa
[email protected]
813-955-2593

http://www.hsc.usf.edu

Share12Tweet7Share2ShareShareShare1

Related Posts

Researchers Improve Allergy Testing to Detect Antibodies Behind Reactions

July 15, 2026

Regulatory Hurdles Undermine Cell Therapy Approvals: Lessons from IND and BLA Failures

July 15, 2026

Machine Learning Method Widens Accurate Use of Martin-Hopkins LDL Risk Equation

July 15, 2026

SIRT5-SUCLG2 Desuccinylation Axis Delays Ovarian Aging Through Mitochondrial-Epigenetic Control

July 15, 2026
Please login to join discussion

POPULAR NEWS

  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • A varied menu

    51 shares
    Share 22 Tweet 12
  • 研究人员开发认知工具包,实现阿尔茨海默症早期检测

    50 shares
    Share 20 Tweet 13
  • Porcine Heart Transplant

    50 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Novel Prognostic Biomarker and Oncogenic Driver Identified in Colorectal Cancer

ROS Dynamics Controlled by Polyoxometalate-Functionalized Fe3O4 Nanozyme for Infected Wound Healing

Researchers Improve Allergy Testing to Detect Antibodies Behind Reactions

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.